Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
接受细胞因子抑制剂治疗的免疫介导炎症性疾病患者SARS-CoV-2血清转化率较低。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-020-17703-6
Simon, David; Tascilar, Koray; Krönke, Gerhard; Kleyer, Arnd; Zaiss, Mario M; Heppt, Franz; Meder, Christine; Atreya, Raja; Klenske, Entcho; Dietrich, Peter; Abdullah, Abdullah; Kliem, Thorsten; Corte, Giulia; Morf, Harriet; Leppkes, Moritz; Kremer, Andreas E; Ramming, Andreas; Pachowsky, Milena; Schuch, Florian; Ronneberger, Monika; Kleinert, Stefan; Maier, Clara; Hueber, Axel J; Manger, Karin; Manger, Bernhard; Berking, Carola; Tenbusch, Matthias; Überla, Klaus; Sticherling, Michael; Neurath, Markus F; Schett, Georg
SARS-CoV-2
炎症
炎症/感染
细胞生物学
免疫/内分泌